Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression.

Vaccines (Basel) · 2022 · PMC9783108 · PMID 36560590

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In any mRNA and BNT162b2 subgroups, the booster dose had a better VE than that of the full dose (VED of 17% (95%CI −26% to 60%) and 48% (95%CI −4% to 99%), respectively), yet these results did not reach statistical significance. 3.3.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.